Quick Facts

• Condition 1: Management of xerostomia (dry mouth) following radiation treatment for head and neck cancer.
• Condition 2: Symptomatic management of dry mouth associated with Sjögren’s syndrome.
• Therapeutic Goal: May support the increase of saliva production to help improve oral comfort and function.

---

What Саладжен treats: Main Uses and Benefits

Саладжен (pilocarpine hydrochloride) is a prescription medication used for the management of specific conditions characterized by reduced saliva production. It is used to provide symptomatic relief for individuals experiencing dry mouth (xerostomia).

The medication is indicated for two primary therapeutic domains:

1. Dry Mouth Following Cancer Therapy: It is used to help address symptoms of dry mouth resulting from salivary gland hypofunction, which can occur after radiation treatment for head and neck cancer.

2. Sjögren’s Syndrome: Саладжен is also used for the management of dry mouth symptoms associated with Sjögren’s syndrome, a chronic autoimmune condition.

For many patients, the medication may support an increase in the production of natural saliva. This can help improve the ability to speak and swallow, contributing to overall oral comfort. Symptomatic improvement may begin within a few weeks of starting treatment, with the potential for maximum benefit occurring over several months.

Саладжен (pilocarpine hydrochloride) is primarily used for the symptomatic treatment of dry mouth (xerostomia) caused by two specific conditions in adults: radiation damage to the salivary glands from head and neck cancer treatment, and Sjögren's syndrome, an autoimmune disorder.

Contraindications (Who Cannot Use)

This medication is not appropriate for all patients. It is strictly contraindicated for individuals who have:

• Uncontrolled asthma or other serious, uncontrolled lung conditions, as it can increase airway resistance.
• Narrow-angle (angle-closure) glaucoma or acute iritis (inflammation of the iris), as it can cause pupillary constriction (miosis) that may worsen these eye conditions.
• A known hypersensitivity or allergy to pilocarpine or any of its inactive ingredients.

Warnings and Precautions

Patients with certain other health issues should use Саладжен with caution and under close medical supervision, as the drug may exacerbate their condition. These conditions include:

System	Conditions Requiring Caution
Cardiovascular	Significant heart disease, uncontrolled hypertension (high blood pressure) or hypotension (low blood pressure), and certain cardiac rhythm disturbances.
Gastrointestinal/Urogenital	Active peptic ulcer disease, mechanical obstruction of the urinary tract or GI tract, known or suspected gallstones (cholelithiasis), and kidney stones (nephrolithiasis).

It is generally not recommended for children under 18 years of age due to a lack of safety and efficacy data.

Interactions with other medicines and products for Саладжен

The formal interaction profile for pilocarpine hydrochloride is documented by government regulatory agencies and is structured around its established effect on the cholinergic nervous system and a specific pharmacokinetic finding. The information below details the officially stated interaction patterns.

Interaction Category	Documented Entity and Official Outcome
Pharmacodynamic (PD) Interactions	Parasympathomimetic Agents: Expected to result in additive pharmacologic effects, enhancing the overall cholinergic activity across bodily systems.
	Anticholinergic Drugs (e.g., Atropine): Pilocarpine may antagonize the anticholinergic effects of these medicines, potentially reducing their expected efficacy.
	Beta-Adrenergic Antagonists (Beta-blockers): Co-administration requires caution due to the officially noted potential for conduction disturbances related to additive cardiosuppressive effects.
Pharmacokinetic (PK) Interaction	CYP2A6 Substrates: Pilocarpine is an in vitro inhibitor of the CYP2A6 enzyme. An interaction that may lead to increased plasma exposure of co-administered substrates cannot be ruled out in clinical use.
Food Interaction	High-fat meal: While administration with a high-fat meal decreases the drug’s peak plasma concentration (Cmax), this effect is officially not considered clinically significant by regulators.

The product's interaction structure is defined by the high-level pharmacodynamic effects and this single metabolic caution. The regulatory documentation explicitly notes the need for caution with drugs like beta-blockers. Official labeling does not define any formally contraindicated drug combinations or mandatory dose separation rules for the oral tablet.

Direct Activation of Muscarinic Receptors

Саладжен works as a direct-acting cholinergic agonist by binding to and activating muscarinic acetylcholine receptors ( mAChRs), primarily the M3 subtype ( M3 R), found on exocrine gland cells. This initial molecular binding initiates a strong signal via the M3 R, providing the necessary biological trigger to initiate parasympathetic signaling at the effector cell.

The Intracellular Secretagogue Cascade

Activation of the M3 R sets off a precise G q-protein signaling cascade inside the gland cell, which ultimately causes a massive, rapid release of intracellular calcium ions ( Ca^2+). This Ca^2+ surge is the essential molecular event that drives the secretion of ions and water from the cell, resulting in a systemic secretagogue effect—the physiological increase of fluid output from the glands.

Functional Limit of the Mechanism

The mechanism's functional extent is dependent upon the residual capacity of the glandular tissue. Since the action requires functional M3 R and viable acinar cells to execute the intracellular Ca^2+ cascade, the molecular and cellular cascade is functionally inhibited if the target glands are severely or irreversibly destroyed.

How to Use Salagen (Pilocarpine Hydrochloride)

Salagen is an oral medication supplied as a film-coated tablet. The instructions for administration must be followed exactly as prescribed.

---

Administration Protocol

Feature	Guideline
Route of Administration	Oral (by mouth)
Dosage Forms	Tablet, typically 5 mg
Timing with Meals	Tablets must be taken with or immediately after a meal.
Intake Condition	Tablets should be swallowed whole with water and must not be crushed, chewed, or split.

---

Dosing and Frequency

The standard dose is 5 mg, but the frequency depends on the condition being addressed:

• Sjögren's Syndrome: The typical adult regimen is 5 mg taken four times daily (QID).
• Post-Radiation Xerostomia: The typical adult regimen is 5 mg taken three times daily (TID).

Daily dosing limits and specific schedules are determined based on individual clinical requirements.

---

Special Dosing Considerations

Missed Dose: If a dose is forgotten, the patient should skip the missed dose and take the next dose at the regularly scheduled time. Do not take a double dose to compensate for the missed one.

Hepatic Impairment: For patients with moderate liver disease, the starting dose is typically reduced to 5 mg twice daily and adjusted subsequently based on the individual's response and tolerability.

Recent Clinical Evidence: Overview of Studies

Clinical research on Саладжен (pilocarpine hydrochloride) primarily focuses on its use for xerostomia (dry mouth) and xerophthalmia (dry eyes) associated with conditions like Sjögren's syndrome or following head and neck radiotherapy. The compound is a cholinergic parasympathomimetic agent; initial research describes its target activity at muscarinic receptors.

---

Core Efficacy and Phase 3 Data

Phase 3 trials have investigated the compound's potential impact on patient outcomes, particularly increased salivary flow. These studies included randomized, double-blind, placebo-controlled designs over 12 weeks. Key findings reported in medical literature include:

• Salivary Flow: Trials assessed increases in whole saliva flow from baseline, with observed differences compared to placebo. One study found that specific dosages were associated with increased whole saliva flow one hour after administration.
• Symptom Improvement: Patients’ global assessments were used to evaluate changes in dry mouth symptoms, including severity of dryness, oral comfort, and ability to speak without liquids. Statistically significant improvement in the global assessment of dry mouth was observed after several weeks of treatment compared to placebo.

---

Pharmacokinetics and Safety Evaluation

Clinical studies have included evaluation of the compound over an extended duration, contributing to long-term data collection. Pharmacokinetic analysis determined a mean elimination half-life that varies based on the administered dose. In subjects with mild to moderate hepatic impairment, a decrease in total plasma clearance was observed. Post-market surveillance and clinical studies continue to investigate potential interactions with other medications, such as certain enzyme inhibitors.

Common questions about Саладжен (FAQ)

---

Q: Does this medicine need to be stored in the refrigerator?

Official product information suggests that Саладжен is stored at controlled room temperature, which is typically between 20 C and 25 C (68 F and 77 F). Storing it within a slightly wider temperature range is generally permitted, but refrigeration is not required for this medicine.

---

Q: Can I drink alcohol while taking this medication?

Official product labeling advises against the concomitant use of this medication with alcohol. Regulatory documents indicate this is due to an increased risk of central nervous system (CNS) side effects. These effects may include dizziness or feeling unusually sleepy (somnolence).

---

How to Store and Dispose of Salagen (Pilocarpine Hydrochloride)

Regulatory authorities require Salagen tablets to be stored under specific conditions to maintain product stability and effectiveness. The medicine must be kept at a controlled temperature, not exceeding 25°C.

Official Storage Requirements

Condition	Requirement
Temperature	Do not store above 25°C.
Protection	Protect from light and moisture.
Container	Store in the original package.
Shelf-Life	3 years.

Handling and Disposal

To ensure proper stability, the medication must remain in its original packaging (e.g., blister packs), which provides necessary protection from light and moisture. Official government labeling for Salagen tablets does not list specific drug-based hazardous waste instructions. Consequently, any unused or expired product must be disposed of in accordance with local pharmacy or governmental regulations for unused medicines.